Jl. Reverter et al., RELATIONSHIP BETWEEN LIPOPROTEIN PROFILE AND URINARY ALBUMIN EXCRETION IN TYPE-II DIABETIC-PATIENTS WITH STABLE METABOLIC CONTROL, Diabetes care, 17(3), 1994, pp. 189-194
Citations number
30
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
OBJECTIVE - To assess lipids and lipoprotein composition and the relat
ionship between lipoprotein abnormalities and urinary albumin excretio
n (UAE) in select type II diabetic patients with stable metabolic cont
rol. RESEARCH DESIGN AND METHODS - Fifty-five type II diabetic patient
s and 55 healthy control subjects-both with a body mass index <30 kg/m
(2) were studied. Patients were classified according to their level of
UAE as normoalbuminuric (n = 37), microalbuminuric (n = 11), and macr
oalbuminuric (n = 7). In all cases, serum creatinine and albumin conce
ntrations were in the normal range. RESULTS - Normoalbuminuric patient
s showed increased triglyceride (TG) contents in intermediate-density
lipoprotein (IDL) (P < 0.01), low-density lipoprotein (LDL) (P < 0.001
), and high-density lipoprotein (HDL) (P < 0.001) compared with contro
l subjects. Lipoprotein concentration in microalbuminuric patients did
not differ from that of normoalbuminuric patients. On the other hand,
patients with macroalbuminuria showed a significant increase in IDL c
holesterol (P < 0.01) and IDL (P < 0.01), LDL (P < 0.05), and HDL TGs
(P < 0.01) compared with the other groups. Diabetic patients with neph
ropathy, both microalbuminuric and macroalbuminuric, tended to have hi
gher mean lipoprotein(a) (Lp[a]) concentrations than normoalbuminuric
patients and control subjects. A strongly positive correlation was obs
erved between UAE and serum TGs (r = 0.56) and very-low-density lipopr
otein (r = 0.55), IDL (r = 0.52), LDL (r = 0.54), and HDL TGs (r = 0.5
2). CONCLUSIONS - Lipoprotein alterations observed in diabetic patient
s, specifically IDL abnormalities and a tendency toward high Lp(a) lev
els, which are more marked in those with increased UAE, may contribute
to the excess of cardiovascular disease in type II diabetic patients,
particularly those with nephropathy.